p53 isoforms gain functions

被引:0
|
作者
V Olivares-Illana
R Fåhraeus
机构
[1] INSERM Cibles Therapeutiques,
[2] Institut de Génétique Moléculaire,undefined
[3] Université Paris 7,undefined
[4] Hôpital St Louis,undefined
来源
Oncogene | 2010年 / 29卷
关键词
p53; endoplasmic reticulum stress; senescence; alternative gene expression;
D O I
暂无
中图分类号
学科分类号
摘要
Many different cell stress pathways converge on p53 to induce a number of distinct cell biological responses such as G1 or G2 arrest, senescence or apoptosis. One of the outstanding questions with regard to p53 is how the cells can differentiate between different stresses so that p53 activation leads to the correct response. It has been known for some time that the p53 gene expresses isoforms that carry unique domains and properties, and more recent works have started to reveal some of their functions. The alternative mRNA translation product p53/47, which lacks the first 40 codons, including the first of p53's two trans-activation domains, is being linked to endoplasmic reticulum stress and the unfolded protein response to which it causes a specific G2 arrest. On the other hand, p53 itself induces G1 arrest and has no effect on the G2. The two isoforms Δ133p53, which lacks the first 133 amino acids, and p53β, which carries an alternative C-terminus, are derived from alternative promoter usage or splicing, respectively, and are together implied in controlling cellular senescence. Hence, through different mechanisms of gene expression control, alternative levels of p53 isoforms help the cell to differentiate between p53 activation and the response to diverse stresses. This holds promise to a better understanding of how upstream and downstream p53 pathways have evolved relative to specific p53 domains.
引用
收藏
页码:5113 / 5119
页数:6
相关论文
共 50 条
  • [41] Cutaneous immunohistochemical staining pattern of p53β isoforms
    Ko, Christine J.
    Myung, Peggy
    Leffell, David J.
    Bourdon, Jean-Christophe
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (12) : 1120 - 1122
  • [42] p53 Isoforms as Cancer Biomarkers and Therapeutic Targets
    Zhao, Liuqun
    Sanyal, Suparna
    CANCERS, 2022, 14 (13)
  • [43] The do's and don'ts of p53 isoforms
    Jaenicke, Reiner U.
    Graupner, Vilma
    Budach, Wilfried
    Essmann, Frank
    BIOLOGICAL CHEMISTRY, 2009, 390 (10) : 951 - 963
  • [44] Pontin, a novel interactor of mutant p53 that promotes mutant p53 gain of function
    Zhao, Yuhan
    Yue, Xuetian
    Hu, Wenwei
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (02)
  • [45] Expression of p53 isoforms in renal cell carcinoma
    Song Wei
    Huo Shi-wei
    Lue Jia-ju
    Liu Zheng
    Fang Xiao-lei
    Jin Xun-bo
    Yuan Ming-zhen
    CHINESE MEDICAL JOURNAL, 2009, 122 (08) : 921 - 926
  • [46] p53 isoforms, Δ133p53 and p53β, regulate aging-associated T lymphocyte senescence.
    Mondal, Abdul Matin
    Horikawa, Lzumi
    Pine, Sharon R.
    Fujita, Kaori
    Vojtesek, Borivoj
    Bourdon, Jean-Christophe
    Vera, Elsa
    Lane, David P.
    Blasco, Maria A.
    Harris, Curtis C.
    CANCER RESEARCH, 2011, 71
  • [47] Mitochondrial death functions of p53
    Marchenko, N. D.
    Moll, U. M.
    MOLECULAR & CELLULAR ONCOLOGY, 2014, 1 (02):
  • [48] Deconstruction of p53 functions and regulation
    Ygal Haupt
    Ana I Robles
    Carol Prives
    Varda Rotter
    Oncogene, 2002, 21 (54) : 8223 - 8231
  • [49] Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53null Cell Lines
    Silden, Elisabeth
    Hjelle, Sigrun M.
    Wergeland, Line
    Sulen, Andre
    Andresen, Vibeke
    Bourdon, Jean-Christophe
    Micklem, David R.
    McCormack, Emmet
    Gjertsen, Bjorn Tore
    PLOS ONE, 2013, 8 (02):
  • [50] Zebrafish Models of p53 Functions
    Storer, Narie Y.
    Zon, Leonard I.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (08): : a001123